Skip to content

Longitudinal Outcomes in Hepatic Resection

Longitudinal Outcomes in Hepatic Resection

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02997098
Enrollment
0
Registered
2016-12-19
Start date
2017-05-04
Completion date
2037-05-31
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Diseases, Surgery

Keywords

Hepatectomy

Brief summary

This observational registry of patients undergoing liver surgery collects patients both retrospectively and prospectively. Patients undergoing liver resection for any non-transplant indication will be evaluated for clinical outcomes (such as surgical complications, survival, and disease progression) based on clinical and patient factors (like indication, age, and other treatments for the disease).

Interventions

None listed

Sponsors

Duke University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients requiring liver resection

Exclusion criteria

* Patients under the age of 18 years * Patients undergoing liver transplant

Design outcomes

Primary

MeasureTime frame
Overall survival10 years

Secondary

MeasureTime frameDescription
Surgical-site infection3 months
Postoperative bleeding3 months
Blood clot3 months
Disease-free survival10 years
Operative time1 day
Intraoperative blood loss1 day
Number of segments resected1 dayIf applicable
Use of other therapy5 yearse.g., antibiotics in liver abscess, chemotherapy in liver cancer

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026